Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy

Annals of Surgery

Volumn 245, Issue 1, 2007, Pages 44-50

  Veteläinen, Reeta ^a   Van Vliet, Arlène K ^a   Van Gulik, Thomas M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CHOLINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHIONINE; TUMOR NECROSIS FACTOR ALPHA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOPATHOLOGY; INFLAMMATION; KUPFFER CELL; LIVER CELL; LIVER CELL DAMAGE; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PH MEASUREMENT; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; STANDARDIZATION; STEATOSIS; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATECTOMY; HEPATOCYTES; LIPID PEROXIDATION; LIVER REGENERATION; MALE; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX;

EID: 33845948392     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000225253.84501.0e     Document Type: Article

References (35)

1. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241-1246.
2. Paquet KJ, Koussouris P, Mercado MA, et al. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. Br J Surg. 1991;78459-78462.
3. Wu CC, Yang MD, Liu TJ. Improvements in hepatocellular carcinoma resection by intraoperative ultrasonography or intermittent hepatic in-flow blood occlusion. Jpn Clin Oncol. 1992;22:107-111.
4. Hilden M, Christofferson P, Juhl E. Liver histology in a 'normal population': examination of 503 consecutive fatal traffic casualties. Scand J Gastroenterol. 1977;12:593-597.
5. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37:1202-1219.
6. Kooby DA, Fong Y, Suriawanata A. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2004;7:1034-1044.
7. Behrns KE, Tsiotos GG, DeSouza NF, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292-298.
8. Marcos A, Fisher R, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplant. 2000;69:1375-1379.
9. Angulo P. Nonalcoholic fatty liver disease. N Eng J Med. 2002;346:1221-1231.
10. Higgins GM, Anderson RM. Experimental pathology of the liver: restoration of the liver of a white rat following surgical removal. Arch Pathol. 1931;12:186-206.
11. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology. 2000;31:35-42.
12. Gerlach C, Sakkab DY, Scholzen T, et al. Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology. 1997;26:573-578.
13. Fabricant JI. The kinetics of cellular proliferation in regenerating liver. J Cell Biol. 1968;38:551-565.
14. Camargo CA Jr, Madden JF, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology. 1997;26:1513-1520.
15. Serafín A, Roselló-Catafau J, Prats N, et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Path. 2002;161:587-601.
16. Haney A, Peacock EE Jr, Madden JW. Liver regeneration and hepatic collagen deposition in rats with dethylnitrosamine-induced cirrhosis. Morphol Embryol. 1975;21:213-217.
17. Bismuth H, Chiche L, Adam R. Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation. Transplant Proc. 1993;25:1066-1067.
18. Fan ST, Lai EC, Lo CM, et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995; 130:198-203.
19. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis. 2001;21:89-104.
20. Caraceni P, Nardo B, Domenicali M, et al. Ischemia-reperfusion injury in the rat fatty liver: the role of nutritional status. Hepatology. 1999;29: 1139-1146.
21. Koppe SW, Sahai A, Malladi P, et al. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J Hepatol. 2004;4:592-598.
22. Fernandez FG, Ritter J, Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaplatin pretreatment on respectability of hepatic colorectal metastases. J Am Coll Surg. 2005;200:845-853.
23. Rao MS, Pafreddy K, Abecassis M, et al. Regeneration of fatty liver with marked fatty change following partial hepatectomy in rats. Dig Dis Dis. 2001;9:1821-1826.
24. Picard C, Lambotte L, Starkel P, et al. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol. 2002;32:645-652.
25. Pessayre D, Mansouri A, Fromety B. Nonalcoholic steatosis and steatohepatitis: V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2002;282:G139-G199.
26. Leclerq I, Farrell G, Field J, et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxidation in murine nonalcoholic steatohepatitis. J Clin Invest. 2000;105:1067-1075.
27. Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity. Toxic Sci. 2002;65:166-176.
28. Yang SQ, Lin HZ, Mandal AK, et al. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathology. Hepatology. 2003;34:694-706.
29. McCuskey RS, Ito Y, Robertson GR, et al. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology. 2004; 40:386-393.
30. Yang SQ, Lin HZ, Lane MD, et al. Obesity increases sensitivity to endotoxin liver injury: implications for pathogenesis of steatohepatitis. Proc Natl Acad Sci USA. 1997;94:2557-2562.
31. Yokoyama H, Fukuda M, Okamura Y, et al. Superoxide anion release into the hepatic sinusoid after an acute ethanol challenge and its attenuation by Kupffer cell depletion. Alcohol Clin Exp Res. 1999;123(suppl):71.
32. Iimuro Y, Gallucci YM, Luster MI, et al. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology. 1997;26:1530-1538.
33. Enomoto N, Ikejima K, Yamashima S, et al. Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res. 2001;25(suppl):51-54.
34. Prins HA, Meijer C, Boelens PG. Kupffer-cell-depleted rats have a diminished acute-phase response following major liver resection. Shock. 2004;21:561-565.
35. Mayeux PR. Pathobiology of lipopolysaccharide. J Toxicol Environ Health. 1997;51:415-435.